Organic Active Ingredients TRIZ Cases

Supra-auricular filler injection expands facial tissue volume to restore structural contours.

Tryptophan metabolites attenuate cytokine storms in ARDS while preserving infection defense mechanisms.

A dissoluble microneedle drug delivery system utilizes replaceable inner matrices to administer vaccines through the skin.

Composite hyaluronic acid oligosaccharides resolve the permeability-retention trade-off by conjugating hydrophilic chains with hydrophobic fatty acid moieties.

Luteolin disrupts abnormal PACT-PKR heterodimer formation to reduce cellular stress responses.

Biocompatible focused ultrasound collapses gas vesicles to trigger mechanochemical cargo release from mechanophore-functionalized polymers.

Novel non-hormonal steroid compounds inhibit IκB kinases to block the NF-κB pathway.

Introducing an oxetane substituent to pyridine structures enhances anti-fibrotic efficacy against IPF beyond Pirfenidone limits.

Combining formula I compounds with anticancer drugs reduces required dosages, reverses immunosuppression, and attenuates cachexia symptoms.

Substituted pyrimidine derivatives inhibit tropomyosin-related kinase family proteins to treat cancer, pain, and inflammation.

Human milk oligosaccharides activate GPR35 receptors to reduce nociception without analgesic side effects.

Dissociation methods create representative tumor homogenates to capture spatial heterogeneity and detect minor subclones.

Conjugated graphene oxide and hyaluronic acid deliver tankyrase inhibitors to reduce fibrosis without dermal atrophy.

Azacyclyl-substituted aryldihydroisoquinolinones resolve solubility and metabolic stability trade-offs while maintaining nanomolar MCH1R blockade.

Crystalline apilimod salts prevent chemical degradation of dry powder blends, ensuring stable oral dosage forms for neurodegenerative disease treatment.

Inhibiting H3K9me1/2 methyltransferases resolves the contradiction between cell type diversity and accurate tissue representation in lung organoids.

Pyrazole linked benzimidazole conjugates inhibit tubulin polymerization and modulate protein kinase activity.

Removing monosaccharide moieties from paromomycin reduces mammalian toxicity and antimicrobial activity while maintaining stop codon suppression.

A mesylate salt of a pyridinylaminopyrimidine derivative enhances bioavailability and tumor growth inhibition in animal models.

Sterile multi-stage fermentation grows Euglena at high density to produce bioavailable beta-1,3-glucan while preventing contamination.

A transdermal patch system uses a porator to create micropores in the skin for hydrophilic permeant delivery.

CRF1 receptor antagonists inhibit ACTH release, enabling lower glucocorticoid doses that reduce iatrogenic Cushing's syndrome risk.

Amorphous tapentadol phosphate prevents rapid liquefaction by shifting from crystalline to amorphous form, ensuring pharmaceutical stability.

Novel polycyclic carbamoylpyridone compounds inhibit HIV integrase to suppress viral replication.

Antisense oligonucleotides reduce RNA foci and dipeptide repeat protein toxicity in ALS models.

A 5-benzylaminosalicylic acid compound composition treats cognitive dysfunction in companion animals.

Novel tricyclic pyrrolopyridine compounds act as potent JAK inhibitors.

Modified pyrazolopyrimidinones improve CNS penetration to treat brain tumors despite poor blood-brain barrier crossing.

Substituted pyridinyl compounds activate Kv3.1 and Kv3.2 channels to restore fast-spiking interneuron function.

Injectable carbohydrate composition enhances hydration and lubrication at the osteotendinous junction.

Merges estrogen and vitamin D in a single vaginal formulation to increase epithelium thickness while minimizing systemic absorption risks.

A benzothiophene alkyl ether derivative promotes neural stem cell proliferation and differentiation to induce neurogenesis.

NK-1 receptor-binding conjugates deliver therapeutic agents to tumor cells, reducing toxicity to normal host cells.

Organometallic catalysts stabilize organic peroxide bonds during synthesis, resolving side reactions in carbazole integration.

An aqueous-based emulsion spray sustains corticosteroid release to reduce skin irritation and improve patient compliance.

An anti-human CCR7 antibody binds the extracellular domain to block intracellular signaling.

Water solvent crystallization yields pure organic acids without organic solvents, reducing process complexity and energy consumption.

Nanoparticles carry cannabinoid receptor binding agents through the skin barrier, resolving insufficient penetration and limited therapeutic efficacy.

A carboxymethyl starch and phospholipid inclusion complex enables sustained active ingredient release.

A process introducing orthogonal ester and alkyne handles into siRNA strands for targeted chemical modification.

Adenosine deaminase base editor 8 corrects G6PC mutations without inducing random indels.

A screening method uses laminin 511 expression levels to promote epidermal basal stem cells.

Chloropyrimidine derivatives act as GLP-1 receptor agonists to lower fasting blood glucose and reduce side effects in type 2 diabetes treatment.

LPA RNA interference agent targets nucleic acid molecules encoding LPA to inhibit gene expression in liver cells.